Semaglutide and pregnancy: what the evidence actually says

Is semaglutide safe to take during pregnancy?

The short answer is no, and this is not a grey area. Semaglutide is not licensed for use in pregnancy, and both the manufacturer's guidance and NHS clinical advice recommend against it. Animal reproduction studies showed harmful effects on foetal development, including reduced foetal weight, skeletal abnormalities and increased rates of early pregnancy loss, at doses that produce exposure levels similar to those in humans receiving the therapeutic dose. If you want to understand in detail how semaglutide affects pregnancy, including what the animal and human data actually show, that page brings the evidence together in one place. There are no adequate, well-controlled studies in pregnant women, and the precautionary principle applies firmly here.

The NHS medicines information for semaglutide confirms that the medicine should not be used in pregnancy. Because obesity itself carries obstetric risks, the clinical picture is genuinely complex, but that complexity is exactly why decisions about weight management before, during and after pregnancy belong with a GP, obstetrician or specialist, not a self-managed plan.

If you became pregnant while taking Wegovy, stop the medicine and speak to your GP or midwife as soon as possible. Reporting the pregnancy to the manufacturer's pharmacovigilance registry is also encouraged, since real-world human data is currently limited and every case helps build the evidence base over time.

How long before trying to conceive should semaglutide be stopped?

NHS guidance recommends stopping semaglutide at least two months before trying to conceive. Semaglutide has a half-life of roughly one week, meaning it takes several weeks to clear from the body after the last dose, the two-month window accounts for this and adds a safety margin.

This timeline matters for practical planning. If you are weighing up when to pause treatment, it is worth having that conversation with your prescriber well in advance rather than stopping suddenly when plans change. A question our prescribers hear regularly is whether weight regain during the washout period is inevitable, the honest answer is that some regain is common, and a prescriber can help you think through lifestyle strategies for that window. You can read more detail on taking Wegovy while trying to conceive in a dedicated resource.

Contraception is relevant here too. The NHS England wraparound care guidance for weight-management injections advises that reliable contraception is used throughout treatment and during the washout period. For tirzepatide there is a specific interaction with oral contraceptives, but for semaglutide there is no equivalent evidence of reduced pill effectiveness, your prescriber or GP can advise based on your contraception method.

What if I discover I'm pregnant while on Wegovy?

Stop the injection and contact your GP or midwifery team promptly. This is the consistent advice from the prescribing information and from NHS guidance, there is no benefit to completing a weekly dose you have not yet taken, and early contact with your maternity team means any monitoring decisions can be made with full information.

The effects of semaglutide on a pregnancy that has already begun are genuinely uncertain in humans. Animal data raised concern; incidental human exposures reported in the literature have not established a clear pattern of harm, but the numbers are too small to draw reassuring conclusions. Uncertainty is not the same as safety. Your obstetrician or midwife will be best placed to advise on any additional monitoring that may be appropriate. For a broader look at semaglutide and pregnancy, including what limited human data exists, that page covers the topic in more depth.

The emotional side of this situation (particularly if the pregnancy was planned and treatment was going well) is worth acknowledging. Stopping a medicine that was working is difficult. A GP can help you plan a return to treatment after delivery and once breastfeeding has ended, if that is appropriate for you.

Can semaglutide affect fertility, and does Wegovy interact with hormones?

There is no established clinical evidence that semaglutide directly impairs fertility in humans. However, weight loss itself affects hormonal profiles, particularly in women with conditions such as polycystic ovary syndrome, and this can increase fertility. That is not a theoretical risk, it is one reason prescribers emphasise reliable contraception throughout treatment, including in the early weeks before significant weight change occurs.

The broader question of how Wegovy interacts with reproductive hormones is still being characterised. The cardiovascular and systemic effects of Wegovy are well-studied; its reproductive endocrinology is less so. If you have a condition that affects fertility or hormone balance, your specialist (not just a weight-management prescriber) should be involved in the conversation before you start or stop treatment. The same applies if you are on hormone treatments such as HRT; NHS guidance flags potential absorption considerations for those on certain forms of hormonal therapy alongside GLP-1 medicines.

If you have questions about liver health alongside weight management, our overview of how semaglutide affects the liver may also be relevant, given the established links between metabolic health, fatty liver and hormonal balance.

If you would like to talk through your situation with a clinician, our prescribers are available seven days a week. You can start your free consultation at any point, and the review is carried out by a GPhC-registered Independent Prescriber who reads your answers personally.